China Universal Asset Management Company’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
VCM
PCM
VPM
GCL
China Universal Asset Management Company's FOLD Position: Q1 2026 in Review
China Universal Asset Management Company sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 50,275 shares — an estimated $716K sold.
China Universal Asset Management Company first reported a position in FOLD in Q3 2022 and held it in 14 quarters. The position peaked at $716K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- China Universal Asset Management Company reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
- China Universal Asset Management Company sold 50,275 Amicus Therapeutics shares in Q1 2026, an estimated $716K.
- China Universal Asset Management Company first reported a position in Amicus Therapeutics in Q3 2022 and held it in 14 quarters.
- China Universal Asset Management Company's Amicus Therapeutics position peaked at $716K in Q4 2025.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.